| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
5,850 |
720 |
$136K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,387 |
1,705 |
$92K |
| 87481 |
|
3,446 |
698 |
$83K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,786 |
1,551 |
$49K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,781 |
1,547 |
$48K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,621 |
1,412 |
$43K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,780 |
1,542 |
$30K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
696 |
613 |
$20K |
| 87511 |
|
828 |
703 |
$17K |
| 88342 |
|
339 |
326 |
$16K |
| 88307 |
|
99 |
97 |
$10K |
| 88313 |
|
54 |
54 |
$6K |
| 88304 |
|
192 |
189 |
$3K |
| 88141 |
|
293 |
255 |
$2K |
| 87653 |
|
64 |
51 |
$2K |
| 87631 |
|
13 |
13 |
$958.48 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27 |
14 |
$731.40 |
| 87486 |
|
13 |
13 |
$235.84 |
| 87541 |
|
13 |
13 |
$235.84 |
| 87581 |
|
13 |
13 |
$235.84 |
| 87640 |
|
13 |
13 |
$235.84 |
| 88302 |
|
28 |
28 |
$195.01 |